Evaluation of biomarkers of exposure in adult cigarette smokers using Marlboro Snus

Nicotine and Tobacco Research

Volumn 12, Issue 2, 2010, Pages 105-116

  Sarkar, Mohamadi ^a   Liu, Jianmin ^a   Koval, Tamara ^a   Wang, Jingzhu ^a   Feng, Shixia ^a   Serafin, Richard ^a   Jin, Yan ^b   Xie, Yuli ^c   Newland, Kirk ^c   Roethig, Hans J ^a  

^a Center for Research and Technology   (United States)

^b Altria Client Services   (United States)

^c Pharma Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLANILINE; 2 NAPHTHYLAMINE; 3 HYDROXYBENZO[A]PYRENE; 3' HYDROXYCOTININE; 4 BIPHENYLAMINE; AROMATIC AMINE; BENZENE; BIOLOGICAL MARKER; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; COTININE; NICOTINE; NITROSAMINE; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BLOOD LEVEL; BLOOD SAMPLING; CIGARETTE SMOKING; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; METABOLITE; MUTAGENICITY; PRIORITY JOURNAL; SMOKELESS TOBACCO; SMOKING CESSATION; TANDEM MASS SPECTROMETRY; URINE LEVEL;

ADMINISTRATION, INHALATION; ADULT; BIOLOGICAL MARKERS; BUTADIENES; CARBON MONOXIDE; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; INHALATION EXPOSURE; MALE; MIDDLE AGED; NICOTINE; NITROSAMINES; PYRENES; SMOKE; SMOKING; TOBACCO, SMOKELESS; YOUNG ADULT;

EID: 77950258356     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntp183     Document Type: Article

References (48)

1. Adams, J. D., Lavoie, E. J., O'Mara-Adams, K. J., Hoffmann, D., Carey, K. D., & Marshall, M. V. (1985). Pharmacokinetics of N?-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)- 1-butanone in laboratory animals. Cancer Letters, 28, 195-201.
2. Backinger, C. L., Fagan, P., O'Connell, M. E., Grana, R., Lawrence, D., Bishop, J. A., et al. (2008). Use of other tobacco products among U.S. adult cigarette smokers: Prevalence, trends and correlates. Addictive Behaviors, 33, 472-489.
3. Benowitz, N. L., & Jacob, P., III (2001). Trans-3′-hydroxycotinine: Disposition kinetics, effects and plasma levels during cigarette smoking. British Journal of Clinical Pharmacology, 51, 53-59.
4. Benowitz, N. L., Jacob, P., III, & Denaro, C.Jenkins, R. (1991). Stable isotope studies of nicotine kinetics and bioavailability. Clinical Pharmacology and Therapeutics, 49, 270-277.
5. Biener, L. & Bogen, K. (2009). Receptivity to Taboka and Camel Snus in a U.S. test market. Nicotine and Tobacco Research, 10, 1154-1159.
6. Boffetta, P., Hecht, S., Gray, N., Gupta, P., & Straif, K. (2008). Smokeless tobacco and cancer. Lancet Oncology, 9, 667-675.
7. Bombard, J. M., Pederson, L. L., Nelson, D. E., & Malarcher, A. M. (2007). Are smokers only using cigarettes? Exploring current polytobacco use among an adult population. Addictive Behaviors, 32, 2411-2419.
8. Curvall, M., Elwin, C. E., Kazemi-Vala, E., Warholm, C., & Enzell, C. R. (1990). The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. European Journal of Clinical Pharmacology, 38, 281-287.
9. Daniel, R. H., Roth, A. B., & Liu, X. (2005). Health risks of smoking compared to Swedish snus. Inhalation Toxicology, 17, 741-748.
10. Dor, F., Dab, W., Empereur-Bissonnet, P., & Zmirou, D. (1999). Validity of biomarkers in environmental health studies: The case of PAHs and benzene. Critical Reviews in Toxicology, 29, 129-168.
11. el Bayoumy, K., Donahue, J. M., Hecht, S. S., & Hoffmann, D. (1986). Identification and quantitative determination of aniline and toluidines in human urine. Cancer Research, 46, 6064-6067.
12. Feng, S., Roethig, H. J., Liang, Q., Kinser, R., Jin, Y., Scherer, G., et al. (2006). Evaluation of urinary 1-hydroxypyrene, S-phenylmercapturic acid, trans,trans-muconic acid, 3-methyladenine, 3-ethyladenine, 8-hydroxy-2′-deoxyguanosine and thioethers as biomarkers of exposure to cigarette smoke. Biomarkers, 11, 28-52.
13. Food and Drug Administration. (2001). Guidance for industry for bioanalytical method validation, 2-14-2008. U.S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research (CDER). Center for Veterinary Medicine (CVM).
14. Furberg, H., Bulik, C. M., Lerman, C., Lichtenstein, P., Pedersen, N. L., & Sullivan, P. F. (2005). Is Swedish snus associated with smoking initiation or smoking cessation? Tobacco Control, 14, 422-424.
15. Furberg, H., Lichtenstein, P., Pedersen, N. L., Bulik, C. M., Lerman, C., & Sullivan, P. F. (2008). Snus use and other correlates of smoking cessation in the Swedish Twin Registry. Psychology and Medicine, 38, 1299-1308.
16. Furberg, H., Lichtenstein, P., Pedersen, N. L., Bulik, C., & Sullivan, P. F. (2006). Cigarettes and oral snuff use in Sweden: Prevalence and transitions. Addiction, 101, 1509-1515.
17. Godtfredsen, N. S., Prescott, E., & Osler, M. (2005). Effect of smoking reduction on lung cancer risk. Journal of American Medical Association, 294, 1505-1510.
18. Hatsukami, D. K., Le, C. T., Zhang, Y., Joseph, A. M., Mooney, M. E., Carmella, S. G., et al. (2006). Toxicant exposure in cigarette reducers versus light smokers. Cancer Epidemiology Biomarkers and Prevention, 15, 2355-2358.
19. Hatsukami, D. K., Lemmonds, C., Zhang, Y., Murphy, S. E., Le, C., Carmella, S. G., et al. (2004). Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. Journal of National Cancer Institute, 96, 844-852.
20. Hecht, S. S., Carmella, S. G., Edmonds, A., Murphy, S. E., Stepanov, I., Luo, X., et al. (2008). Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco. Tobacco Control, 17, 128-131.
21. Hecht, S. S., Carmella, S. G., Murphy, S. E., Akerkar, S., Brunnemann, K. D., & Hoffmann, D. (1993). A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. New England Journal of Medicine, 329, 1543-1546.
22. Hecht, S. S., Carmella, S. G., Murphy, S. E., Riley, W. T., Le, C., Luo, X., et al. (2007). Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiology Biomarkers and Prevention, 16, 1567-1572.
23. Hecht, S. S., Murphy, S. E., Carmella, S. G., Zimmerman, C. L., Losey, L., Kramarczuk, I., et al. (2004). Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen. Journal of the National Cancer Institute., 96, 107-115.
24. Hellqvist, L., Rolandsson, M., Birkhed, D., & Hugoson, A. (2009). Tobacco use in relation to socioeconomic factors and dental care habits among Swedish individuals 15-70 years of age, 1983-2003. International Journal of Dental Hygienists, 7, 62-70.
25. Hergens, M. P., Ahlbom, A., Andersson, T., & Pershagen, G. (2005). Swedish moist snuff and myocardial infarction among men. Epidemiology, 16, 12-16. Huhtasaari, F., Asplund, K., Lundberg, V., Stegmayr, B., & Wester, P. O. (1992). Tobacco and myocardial infarction: Is snuff less dangerous than cigarettes? British Medical Journal, 305, 1252-1256.
26. Huhtasaari, F., Asplund, K., Lundberg, V., Stegmayr, B., & Wester, P. O. (1992). Tobacco and myocardial infarction: Is snuff less dangerous than cigarettes? British Medical Journal, 305, 1252-1256.
27. Huhtasaari, F., Lundberg, V., Eliasson, M., Janlert, U., & Asplund, K. (1999). Smokeless tobacco as a possible risk factor for myocardial infarction: A population-based study in middle-aged men. Journal of American College of Cardiology, 34, 1784-1790.
28. Idris, A. M., Ibrahim, S. O., Vasstrand, E. N., Johannessen, A. C., Lillehaug, J. R., Magnusson, B., et al. (1998). The Swedish snus and the Sudanese toombak: Are they different? Oral Oncology, 34, 558-566.
29. Idris, A. M., Nair, J., Friesen, M., Ohshima, H., Brouet, I., Faustman, E. M., et al. (1992). Carcinogenic tobacco-specific nitrosamines are present at unusually high levels in the saliva of oral snuff users in Sudan. Carcinogenesis, 13, 1001-1005.
30. Kotlyar, M., Mendoza-Baumgart, M. I., Li, Z. Z., Pentel, P. R., Barnett, B. C., Feuer, R. M., et al. (2007). Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge. Tobacco Control, 16, 138-142.
31. Levy, D. T., Mumford, E. A., Cummings, K. M., Gilpin, E. A., Giovino, G., Hyland, A., et al. (2004). The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: Estimates of a panel of experts. Cancer Epidemiology Biomarkers and Prevention, 13, 2035-2042.
32. Levy, D. T., Mumford, E. A., Cummings, K. M., Gilpin, E. A., Giovino, G. A., Hyland, A., et al. (2005). The potential impact of a low-nitrosamine smokeless tobacco product on cigarette smoking in the United States: Estimates of a panel of experts. Addictive Behaviors, 31, 1190-1200.
33. Luo, J., Ye, W., Zendehdel, K., Adami, J., Adami, H. O., Boffetta, P., et al. (2007). Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: A retrospective cohort study 2. Lancet, 369, 2015-2020.
34. Maron, D. M., & Ames, B. N. (1983). Revised methods for the Salmonella mutagenicity test. Mutation Research, 113, 173-215.
35. Post, A., Gilljam, H., Rosendahl, I., Meurling, L., Bremberg, S., & Galanti, M. R. (2005). Validity of self reports in a cohort of Swedish adolescent smokers and smokeless tobacco (snus) users. Tobacco Control, 14, 114-117.
36. Rickert, W. S., Joza, P. J., Trivedi, A. H., Momin, R. A., Wagstaff, W. G., & Lauterbach, J. H. (2009). Chemical and toxicological characterization of commercial smokeless tobacco products available on the Canadian market. Regulatory Toxicology and Pharmacology, 53, 121-133.
37. Rickham, P. P. (1964). Human experimentation. Code of Ethics of the World Medical Association. Declaration of Helsinki. British Medical Journal, 2, 177.
38. Riedel, K., Scherer, G., Engl, J., Hagedorn, H. W., & Tricker, A. R. (2006). Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers. Journal of Analytical Toxicology, 30, 187-195.
39. Roethig, H. J., Zedler, B. K., Kinser, R. D., Feng, S., Nelson, B. L., & Liang, Q. (2007). Short-term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system. Journal of Clinical Pharmacology, 47, 518-530.
40. Rosa, M., Pacifici, R., Altieri, I., Pichini, S., Ottaviani, G., & Zuccaro, P. (1992). How the steady-state cotinine concentration in cigarette smokers is directly related to nicotine intake. Clinical Pharmacology and Therapeutics, 52, 324-329.
41. Sarkar, M., Kapur, S., Frost-Pineda, K., Feng, S., Wang, J., Liang, Q., et al. (2008). Evaluation of biomarkers of exposure to selected cigarette smoke constituents in adult smokers switched to carbon filtered cigarettes in short term and long term clinical studies. Nicotine. & Tobacco Research, 10, 1761-1772.
42. Sarkar, M., Nseyo, U., & Zhong, B. Z. (2002). Mutagenic outcome of the urinary carcinogen 4-aminobiphenyl is increased in acidic pH. Environmental Toxicology, 11, 23-26.
43. Stepanov, I., Hecht, S. S., Ramakrishnan, S., & Gupta, P. C. (2005). Tobacco-specific nitrosamines in smokeless tobacco products marketed in India. International Journal of Cancer, 116, 16-19.
44. Stepanov, I., Jensen, J., Hatsukami, D., & Hecht, S. S. (2008). New and traditional smokeless tobacco: Comparison of toxicant and carcinogen levels. Nicotine & Tobacco Research, 10, 1773-1782.
45. Strickland, P., & Kang, D. (1999). Urinary 1-hydroxypyrene and other PAH metabolites as biomarkers of exposure to environmental PAH in air particulate matter. Toxicology Letters, 108, 191-199.
46. Tobacco Advisory Group of the Royal College of Physicians. (2007). Harm reduction in nicotine addiction: Helping people who can't quit. A report by the Tobacco Advisory Group of the Royal College of Physicians. London: Royal College of Physicians of London.
47. Wasnik, K. S., Ughade, S. N., Zodpey, S. P., & Ingole, D. L. (1998). Tobacco consumption practices and risk of oro-pharyngeal cancer: A case-control study in Central India. Southeast Asian Journal of Tropical Medicine and Public Health, 29, 827-834.
48. Wetter, D. W., McClure, J. B., de Moor, C., Cofta-Gunn, L., Cummings, S., Cinciripini, P. M., et al. (2002). Concomitant use of cigarettes and smokeless tobacco: Prevalence, correlates, and predictors of tobacco cessation. Preventive Medicine, 34, 638-648.